Phillip Kremer,Thorsten Wiech,Ina Kötter et al.
Phillip Kremer et al.
Background: Systemic amyloidoses are a heterogeneous group of rare diseases characterized by deposition of misfolded proteins. Amyloid A (AA) amyloidosis results from chronic inflammatory processes, with autoinflammatory ...
[Aldosterone synthase inhibitors: a new group of drugs for influencing blood pressure in the renin-angiotensin-aldosterone system] [0.03%]
醛固酮合酶抑制剂：影响肾素血管紧张素醛固酮系统的降压新药
Markus van der Giet
Markus van der Giet
Despite the development of numerous drugs for the treatment of high blood pressure, there are still many difficulties in achieving successful treatment of patients with high blood pressure in routine clinical practice. The renin-angiotensin...
[Beta-blockers following myocardial infarction without heart failure: their role in the era of coronary reperfusion] [0.03%]
无心力衰竭的急性心梗患者使用β受体阻滞剂的意义——冠脉再通治疗时代(beta阻滞剂继发于心肌梗死而不必伴有心力衰竭：在冠状动脉再循环的时代的作用)
Samuel Lee,Stephan Baldus
Samuel Lee
The use of a beta-blocker has been an integral part of treatment following myocardial infarction for decades. However, some of the studies on which this treatment recommendation is based were carried out half a century ago. In the meantime,...
Christoph Schöbel,Claus F Vogelmeier
Christoph Schöbel
[A treacherous pet] [0.03%]
[一只狡诈的宠物]
Livia Baldini,Kiyoshi Sugimoto,Urs Karrer et al.
Livia Baldini et al.
A 63-year-old woman presented with a 5-day history of high-grade fever, petechiae on the lower legs and severe thrombocytopenia. Clinical findings included left inguinal lymphadenopathy and an encrusted wound on the left tibia, which the pa...
[What is established in the treatment of diffuse large B-cell lymphoma?] [0.03%]
弥漫性大B细胞淋巴瘤的治疗现状是什么？
Stefan K Alig,H Christian Reinhardt,Bastian von Tresckow
Stefan K Alig
Diffuse large B‑cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma, with a median age at diagnosis of 71 years, predominantly affecting older adults. Risk factors include immunodeficiency, autoimmune disorders, viral ...
[What is confirmed in the treatment of difficult-to-control arterial hypertension?] [0.03%]
[难治性动脉高血压治疗的确证方法?]
C Beger,F P Limbourg
C Beger
Resistant hypertension is defined as blood pressure remaining above the target level despite treatment with three different antihypertensive agents, including a diuretic, prescribed at maximum or maximally tolerated doses. Prior to any esca...
Malte Verheyen,Lea Ruge,Felix John et al.
Malte Verheyen et al.
Non-small cell lung cancer (NSCLC) is among the most common and lethal malignancies worldwide, representing a particular oncological challenge due to its frequent diagnosis at an advanced, metastatic stage. Histopathologically, NSCLC is bro...